Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - candesartanum - comprimate - 8 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - celecoxibum - capsule - 100 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

labormed pharma s.a. - captoprilum - comprimate - 25 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

labormed pharma s.a. - captoprilum - comprimate - 50 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - celecoxibum - capsule - 200 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

takeda pharma a/s - azilsartan medoxomil - hipertensiune - agenți care acționează asupra sistemului renină-angiotensină - edarbi este indicat pentru tratamentul hipertensiunii esențiale la adulți.

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Uniunea Europeană - română - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Uniunea Europeană - română - EMA (European Medicines Agency)

intervet international bv - tildipirosin - antiinfectioase pentru uz sistemic - pigs; cattle - 40 mg/ml, soluție injectabilă pentru pigstreatment și metaphylaxis bolilor respiratorii la suine (srd) asociate cu actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica și haemophilus parasuis sensibile la tildipirozină. prezența bolii în efectiv trebuie confirmată înainte de punerea în aplicare a metafilaxiei. 180 mg/ml, soluție injectabilă pentru cattlefor tratamentul și prevenirea bolilor respiratorii la bovine (brb) asociate cu mannheimia haemolytica, pasteurella multocida și histophilus somni sensibile la tildipirozină. prezența bolii în efectiv trebuie confirmată înainte de tratamentul preventiv.